Skip to Main content

Co-authors

Number of documents

18

Thierry Soussi: publications


-


Journal articles18 documents

  • Lawrence Donehower, Thierry Soussi, Anil Korkut, Yuexin Liu, Andre Schultz, et al.. Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. Cell Reports, Elsevier Inc, 2019, 28 (5), pp.1370-1384.e5. ⟨10.1016/j.celrep.2019.07.001⟩. ⟨hal-02281902⟩
  • Shaoyi Zhang, Yan Wang, Wei Xie, Ethan Howe, Nathalie Busschaert, et al.. Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux. Cell Death and Disease, Nature Publishing Group, 2019, 10 (3), pp.242. ⟨10.1038/s41419-019-1474-8⟩. ⟨hal-02095603⟩
  • Jesse Salk, Kaitlyn Loubet-Senear, Elisabeth Maritschnegg, Charles Valentine, Lindsey Williams, et al.. Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan. Cell Reports, Elsevier Inc, 2019, 28 (1), pp.132-144.e3. ⟨10.1016/j.celrep.2019.05.109⟩. ⟨hal-02180268⟩
  • Sue Haupt, Franco Caramia, Alan Herschtal, Thierry Soussi, Guillermina Lozano, et al.. Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network. Nature Communications, Nature Publishing Group, 2019, 10, pp.5385. ⟨10.1038/s41467-019-13266-3⟩. ⟨hal-02406712⟩
  • Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, et al.. Emergence and evolution of TP53 mutations are a key feature of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.. Haematologica, Ferrata Storti Foundation, 2018, Epub ahead of print. ⟨10.3324/haematol.2017.181404⟩. ⟨inserm-01691580⟩
  • Bernard Leroy, Mandy Ballinger, Fanny Baran-Marszak, Gareth Bond, Antony Braithwaite, et al.. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. Cancer Research, American Association for Cancer Research, 2017, 77 (6), pp.1250-1260. ⟨10.1158/0008-5472.CAN-16-2179⟩. ⟨hal-02343459⟩
  • Gregory Lazarian, Eugen Tausch, Virginie Eclache, Amel Sebaa, Vincent Bianchi, et al.. TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes. International Journal of Cancer, Wiley, 2016, 139 (8), pp.1759-1763. ⟨10.1002/ijc.30222⟩. ⟨hal-02060820⟩
  • L Lodé, F Cymbalista, Thierry Soussi. Genetic profiling of CLL: a ‘TP53 addict’ perspective. Cell Death and Disease, Nature Publishing Group, 2016, 7 (1), pp.e2042. ⟨10.1038/cddis.2015.415⟩. ⟨hal-01332729⟩
  • Bernard Leroy, Jean Louis Fournier, Chikashi Ishioka, Paola Monti, Alberto Inga, et al.. The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. Nucleic Acids Research, Oxford University Press, 2013, 41 (D1), pp.D962 - D969. ⟨10.1093/nar/gks1033⟩. ⟨hal-01590745⟩
  • Karolina Edlund, Ola Larsson, Adam Ameur, Ignas Bunikis, Ulf Gyllensten, et al.. Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors.. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2012, 109 (24), pp.9551-6. ⟨hal-01188067⟩
  • Thierry Soussi, Dalil Hamroun, Linn Hjortsberg, Jean Michel Rubio-Nevado, Jean Louis Fournier, et al.. MUT-TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancera. Human Mutation, Wiley, 2010, 31 (9), pp.1020 - 1025. ⟨10.1002/humu.21313⟩. ⟨hal-01681836⟩
  • Christophe Béroud, Dalil Hamroun, Gwenaelle Collod-Beroud, Catherine Boileau, Thierry Soussi, et al.. UMD (Universal Mutation Database): 2005 update. Human Mutation, Wiley, 2005, 26 (3), pp.184 - 191. ⟨10.1002/humu.20210⟩. ⟨hal-01669907⟩
  • Thierry Soussi, Shunsuke Kato, Pierre P Levy, Chikashi Ishioka. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations.. Human Mutation, Wiley, 2005, 25 (1), pp.6-17. ⟨10.1002/humu.20114⟩. ⟨hal-00597640⟩
  • Emmanuel Maillart, Karen Brengel-Pesce, Delphine Capela, André Roget, Thierry Livache, et al.. Versatile analysis of multiple macromolecular interactions by SPR imaging: application to p53 and DNA interaction. Oncogene, Nature Publishing Group, 2004, 23, pp.5543-5550. ⟨hal-00664871⟩
  • Christophe Béroud, Gwenaëlle Collod-Béroud, Catherine Boileau, Thierry Soussi, Claudine Junien. UMD (Universal mutation database): a generic software to build and analyze locus-specific databases.. Human Mutation, Wiley, 2000, 15 (1), pp.86-94. ⟨10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4⟩. ⟨inserm-00143606⟩
  • Yannick Saintigny, Danielle Rouillard, Brigitte Chaput, Thierry Soussi, Bernard Lopez. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene, Nature Publishing Group, 1999, 18, pp.3553-3663. ⟨cea-01938157⟩
  • Mahvash Tavassoli, Nadège Brunel, Rehana Maher, Newell Johnson, Thierry Soussi. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. International Journal of Cancer, Wiley, 1998, 78 (3), pp.390-391. ⟨10.1002/(SICI)1097-0215(19981029)78:3<390::AID-IJC23>3.0.CO;2-9⟩. ⟨hal-02485485⟩
  • Gwenaelle Collod, Christophe Béroud, Thierry Soussi, Claudine Junien, Catherine Boileau. Software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Research, Oxford University Press, 1996, 24 (1), pp.137-140. ⟨10.1093/nar/24.1.137⟩. ⟨hal-01662876⟩